Israel OKs jab for weak immune system

By Xinhua News Agency

Feb 17, 2022 12:33 am

JERUSALEM: The Israeli Ministry of Health has approved the administration of AstraZeneca's Evusheld Covid-19 drug to people with weakened immune systems.

The antibody drug, which includes two injections of two types of long-acting antibodies given at the same time, is only authorized for those who are not currently infected or have not recently been exposed to an individual infected with the virus.

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

Apple changes Gulf of Mexico to Gulf of America on maps

Taiwan detects 62 Chinese aircraft as US ships transit waters

Ukraine's rare earth elements could help keep US military aid flowing

NASA's 2 stuck astronauts may return to Earth sooner under new plan

After meeting with Trump, Jordan's king says his country opposes displacing Palestinians in Gaza

White House fires USAID inspector general after warning about funding oversight, officials say

Gutting aid, US cedes soft power game to China